Assyro AI
Orange Book product · Brand (NDA)

Anafranil

Clomipramine Hydrochloride

Brand (NDA)NDA 019906TE ABRLD Specgx LLC
Approved
Dec 29, 1989
Application
Brand (NDA)
TE code
AB
Listed patents
0
Anafranil (Clomipramine Hydrochloride) is Specgx LLC's brand-name drug, approved by the FDA under NDA 019906 in 1989. It is a reference-listed drug (RLD) — the approved product that generic ANDA applicants must show their version is equivalent to. Its therapeutic-equivalence code is AB, so the FDA considers it substitutable for the reference brand. 21 approved generics share this drug's active ingredient.

Sourced from the FDA Orange Book

Approval, patents, exclusivity

Key dates

Key dates

  1. Approval

    FDA approval date of this drug product.

    Dec 29, 1989

    37 yr 1 mo ago

  2. Today

FDA product record

Pharmaceutical detail

Pharmaceutical detail

Active ingredient

CLOMIPRAMINE HYDROCHLORIDE

Strength

50MG

Dosage form

CAPSULE

Route

ORAL

TE code

AB

Application

NDA 019906

Product number

002

Marketing status

Prescription

Reference listed drug (RLD)

Yes

Reference standard (RS)

No

Same application

Other strengths in NDA 019906

Brand + generics

Active-ingredient family

Orange Book patent file

Listed patents

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Anafranil — frequently asked questions

Approval, therapeutic equivalence, patents, and exclusivity for this product, from the FDA Orange Book.

Built directly from the FDA Orange Book data file. This product page links back to the Clomipramine Hydrochloride active-ingredient family, which is the canonical reference for generics, patents, and exclusivity across all strengths.

Related FDA reference tools

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.